Therapeutic mechanism of emodin for treatment of rheumatoid arthritis: a network pharmacology-based analysis.
10.12122/j.issn.1673-4254.2022.06.16
- Author:
Chun Hao CAO
1
;
Li ZENG
1
;
Xiao Feng RONG
1
Author Information
1. Department of Integrated Traditional Chinese and Western Medicine, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
- Publication Type:Journal Article
- Keywords:
emodin;
network pharmacology;
nuclear factor-κB signaling pathway;
rheumatoid arthritis
- MeSH:
Arthritis, Rheumatoid/pathology*;
Emodin/pharmacology*;
Humans;
Molecular Docking Simulation;
NF-kappa B/metabolism*;
Network Pharmacology;
Tumor Necrosis Factor-alpha/pharmacology*
- From:
Journal of Southern Medical University
2022;42(6):913-921
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the therapeutic mechanism of emodin in the treatment of rheumatoid arthritis (RA) using a network pharmacology-based method and validate this mechanism in a fibroblast-like synovial cell line.
METHODS:The PubChem, Targetnet, SwissTargetPrediction, Genecards, OMIM, and DisGeNET databases were searched to obtain emodin targets and RA-related genes. A protein-protein interaction (PPI) network was constructed, and GO and KEGG pathway enrichment analyses were carried out to analyze the intersection genes. AutoDock4.2.6 software was used to simulate molecular docking between emodin and its candidate targets. In a cultured fibroblast-like synovial cell line (MH7A), the effects of different concentrations of emodin on proliferation of tumor necrosis factor-α (TNF-α)-induced cells were investigated using CCK-8 assay, cell scratch experiment and flow cytometry; the changes in the expressions of nuclear factor-κB (NF-κB) pathway proteins were detected using Western blotting, and the mRNA expressions of the hub genes were examined with RT-qPCR.
RESULTS:We identified 32 intersection genes of emodin and RA, and the key targets including CAPS3, ESR1, and MAPK14 involved mainly the NF-κB signaling pathway. Cell scratch experiment and flow cytometry demonstrated a strong inhibitory effect of emodin on MH7A cell proliferation. Treatment with TNF-α significantly increased the cellular expressions of the NF-κB pathway proteins, which were obviously lowered by treatment with 80 μmol/L emodin. The results of RT-qPCR showed that TNF-α treatment obviously up-regulated the expressions of the hub genes COX2 and P38MAPK, and emodin treatment significantly down-regulated the expressions of MAPK and PTGS2 and up-regulated the expression of CASP3.
CONCLUSION:The therapeutic effect of emodin on RA is mediated mainly through regulation of cell proliferation, apoptosis, and the NF-κB pathway.
